Gilead Sciences GILD
NASDAQ GILD
$156.19 -1.18 (-0.75%)
At close: Oct 16, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Change in Intangibles (2019 - 2020)

Updated

Gilead Sciences' Change in Intangibles was $1 billion in Q3 2020, down 75.1% from $4.01 billion a year earlier.

Analysis

Gilead Sciences (GILD) Change in Intangibles (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 3.28 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 437.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 4.32 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 1.00 Bn
Sep 30, 2019 4.01 Bn
API Access

Gilead Sciences Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=GILD&period=max&api_key=YOUR_API_KEY